A detailed history of Colonial Trust Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Colonial Trust Advisors holds 4,202 shares of ABT stock, worth $494,827. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,202
Previous 4,252 1.18%
Holding current value
$494,827
Previous $441,000 8.62%
% of portfolio
0.04%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $5,003 - $5,906
-50 Reduced 1.18%
4,202 $479,000
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $2,014 - $2,248
-20 Reduced 0.47%
4,252 $441,000
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $14,128 - $15,603
-129 Reduced 2.93%
4,272 $485,000
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $3.68 Million - $4.5 Million
-40,806 Reduced 90.26%
4,401 $484,000
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $24,455 - $29,342
-256 Reduced 0.56%
45,207 $4.38 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $283,091 - $315,422
-2,809 Reduced 5.82%
45,463 $4.96 Million
Q1 2023

May 11, 2023

SELL
$96.86 - $114.01 $57,050 - $67,151
-589 Reduced 1.21%
48,272 $4.89 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $532,240 - $624,400
-5,599 Reduced 10.28%
48,861 $5.37 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $117,950 - $136,564
1,219 Added 2.29%
54,460 $5.27 Million
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $85,738 - $103,630
-840 Reduced 1.55%
53,241 $5.79 Million
Q1 2022

May 09, 2022

BUY
$114.02 - $139.04 $239,213 - $291,705
2,098 Added 4.04%
54,081 $6.4 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $53,028 - $64,930
459 Added 0.89%
51,983 $7.32 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $156,207 - $172,811
-1,339 Reduced 2.53%
51,524 $6.09 Million
Q2 2021

Aug 05, 2021

BUY
$105.79 - $124.53 $4.87 Million - $5.74 Million
46,055 Added 676.48%
52,863 $6.13 Million
Q1 2021

May 10, 2021

BUY
$108.84 - $128.23 $1,959 - $2,308
18 Added 0.27%
6,808 $816,000
Q4 2020

Jan 29, 2021

SELL
$105.0 - $114.42 $3,675 - $4,004
-35 Reduced 0.51%
6,790 $743,000
Q3 2020

Oct 26, 2020

SELL
$91.64 - $111.29 $32,074 - $38,951
-350 Reduced 4.88%
6,825 $743,000
Q2 2020

Aug 10, 2020

BUY
$76.57 - $98.0 $47,856 - $61,250
625 Added 9.54%
7,175 $656,000
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $7,851 - $8,740
-100 Reduced 1.5%
6,550 $569,000
Q3 2019

Nov 15, 2019

SELL
$81.84 - $88.74 $4,910 - $5,324
-60 Reduced 0.89%
6,650 $556,000
Q2 2019

Aug 21, 2019

SELL
$72.88 - $85.0 $13,847 - $16,150
-190 Reduced 2.75%
6,710 $564,000
Q1 2019

May 15, 2019

SELL
$66.22 - $80.06 $29,799 - $36,027
-450 Reduced 6.12%
6,900 $552,000
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $25,844 - $31,178
-425 Reduced 5.47%
7,350 $539,000
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $14,392 - $15,885
-250 Reduced 3.12%
7,775 $474,000
Q1 2018

May 10, 2018

SELL
$56.27 - $63.62 $164,252 - $185,706
-2,919 Reduced 26.67%
8,025 $481,000
Q4 2017

Feb 21, 2018

BUY
$53.68 - $57.47 $147,297 - $157,697
2,744 Added 33.46%
10,944 $625,000
Q3 2017

Nov 14, 2017

SELL
$48.06 - $53.64 $14,418 - $16,092
-300 Reduced 3.53%
8,200 $438,000
Q2 2017

Aug 14, 2017

BUY
N/A
8,500
8,500 $413,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Colonial Trust Advisors Portfolio

Follow Colonial Trust Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust Advisors with notifications on news.